AI assistant
Vor Biopharma Inc. — Director's Dealing 2025
Jul 30, 2025
33479_dirs_2025-07-30_ea3d639c-62c3-4c4e-b65f-ea34325ddfcd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vor Biopharma Inc. (VOR)
CIK: 0001817229
Period of Report: 2025-07-17
Reporting Person: Zuraw Qing Che (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-07-17 | Common Stock | A | 937080 | — | Acquired | 937080 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-07-17 | Employee Stock Option (right to buy) | $2.38 | A | 4373040 | Acquired | 2035-07-16 | Common Stock (4373040) | Direct |
Footnotes
F1: Represents the number of shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. 1/4th of the RSUs vest on August 1, 2026, with the remainder vesting in substantially equal quarterly installments over 3 years, in each case subject to the Reporting Person's continued service as of each such date.
F2: 1/4th of the shares underlying the option vest on July 17, 2026, with the remainder vesting in substantially equal monthly installments over 3 years, in each case subject to the Reporting Person's continued service as of each such date.